|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
2 Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Liver Research Institute, University of Arizona, Tucson, AZ, USA
3 Department of Pathology, University of Texas Health Science Center, Houston, TX, USA
* To whom correspondence should be addressed. E-mail: Jaeschke{at}email.arizona.edu.
The hypothesis was tested that the neutrophil chemoattractant CXC chemokines KC and
MIP-2 are involved in neutrophil transmigration and liver injury in C3Heb/FeJ mice
treated with 700 mg/kg galactosamine (Gal) and/or 100 µg/kg endotoxin (ET). Hepatic
KC and MIP-2 mRNA levels and plasma CXC chemokine concentrations were
dramatically increased 1.5 h after Gal/ET or ET alone and gradually declined up to 7 h.
Murine recombinant cytokines (TNF-
, IL-1
, IL-1
), but not Gal/ET, induced CXC
chemokine formation in the endotoxin-resistant C3H/HeJ strain. To assess the functional
importance of KC and MIP-2, C3Heb/FeJ mice were treated with Gal/ET and either
control IgG or a combination of anti-KC and anti-MIP2 antibodies. Anti-CXC chemokine
antibodies did not attenuate hepatocellular apoptosis, sinusoidal neutrophil sequestration
and extravasation, or liver injury at 7 h. Furthermore, there was no difference in liver
injury between Balb/cJ wild-type and CXC receptor-2 gene knock-out mice (CXCR2-/-)
treated with Gal/ET. The higher neutrophil counts in livers of CXCR2-/- mice compared
to wildtype animals after Gal/ET treatment was caused by the elevated number of
neutrophils located in sinusoids of untreated CXCR2-/- animals. The pancaspase inhibitor
Z-VAD-fmk eliminated Gal/ET-induced apoptosis, neutrophil extravasation and injury
but not CXC chemokine formation. Thus, Gal/ET induced massive, cytokine-dependent
CXC chemokine formation in the liver. However, neutrophil extravasation and injury
occurred in response to apoptotic cell injury between 6-7 h and was independent of CXC
chemokine formation.
This article has been cited by other articles:
![]() |
B. Vollmar and M. D. Menger The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair Physiol Rev, October 1, 2009; 89(4): 1269 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Pritchard, S. Roychowdhury, M. R. McMullen, L. Guo, G. E. Arteel, and L. E. Nagy Early growth response-1 contributes to galactosamine/lipopolysaccharide-induced acute liver injury in mice Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1124 - G1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Ramaiah and H. Jaeschke Role of Neutrophils in the Pathogenesis of Acute Inflammatory Liver Injury Toxicol Pathol, October 1, 2007; 35(6): 757 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ito, E. R. Abril, N. W. Bethea, M. K. McCuskey, C. Cover, H. Jaeschke, and R. S. McCuskey Mechanisms and pathophysiological implications of sinusoidal endothelial cell gap formation following treatment with galactosamine/endotoxin in mice Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G211 - G218. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jaeschke Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1083 - G1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, J. F. Maddox, P. E. Ganey, and R. A. Roth Unique Gene Expression and Hepatocellular Injury in the Lipopolysaccharide-Ranitidine Drug Idiosyncrasy Rat Model: Comparison with Famotidine Toxicol. Sci., April 1, 2006; 90(2): 569 - 585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |